KannaLife Sciences Raises $1.5M in Series A Financing

Published On March 7, 2013 |

KannaLife Sciences, Inc., a West Hills, NY-based phyto-medical company that specializes in the research & development of pharmacological products derived from botanical sources, raised $1.5m in Series A financing.

The round was led by and Medical Marijuana Inc. (OTC: MJNA) and CannaVest Corp. (OTC: FCLS).

Led by Dean Petkanas, Founder and Chief Executive Officer, KannaLife Sciences is a late stage bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants.
KannaLife Sciences currently holds an exclusive license with National Institutes of Health – Office of Technology Transfer (“NIH-OTT”) for the Commercialization of U.S. Patent 6,630,507, “Cannabinoids as Antioxidants and Neuroprotectants”.

FinSMEs

07/03/2013

Like this Article? Share it!

Leave a Reply